The above graph depicts a post hoc analysis showing the reduction in average daily pain from baseline in patients who have had DPN for four years or longer. Patients received daily oral doses of either placebo or NYX-2925 throughout the four-week treatment period.
The above graph depicts a post hoc analysis showing the reduction in average daily pain from baseline in patients who have had DPN for four years or longer. Patients received daily oral doses of either placebo or NYX-2925 throughout the four-week treatment period.